STOCK TITAN
  1. Home
  2. News
  3. SGRY

Surgery Partners Inc - SGRY STOCK NEWS

Welcome to our dedicated news page for Surgery Partners (Ticker: SGRY), a resource for investors and traders seeking the latest updates and insights on Surgery Partners.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Surgery Partners's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Surgery Partners's position in the market.

News
Surgery Partners, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call Details
Rhea-AI Summary
Surgery Partners, Inc. (NASDAQ:SGRY) announces the release date of its first quarter 2024 earnings and conference call details. The results will be out on May 7, 2024, followed by a conference call at 8:30 a.m. (Eastern Time). Interested parties can join the call via phone or webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.29%
Tags
earnings
-
News
Surgery Partners, Inc. Announces Pricing of New Senior Notes Offering
Rhea-AI Summary
Surgery Partners, Inc. (NASDAQ: SGRY) announced a private offering of $800 million in senior unsecured notes due 2032 by its subsidiary, Surgery Center Holdings, Inc. The proceeds will be used to redeem existing notes, pay related fees, and fund future acquisitions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.13%
Tags
none
-
News
Surgery Partners, Inc. Announces New Senior Notes Offering
Rhea-AI Summary
Surgery Partners, Inc. (NASDAQ: SGRY) plans to offer $600 million in senior unsecured notes due 2032 through its subsidiary Surgery Center Holdings, Inc. The proceeds will be used to redeem existing notes, pay accrued interest, cover fees, and fund acquisitions. The offering targets qualified institutional buyers in the US and non-US persons under specific regulations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.13%
Tags
none
News
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2023 Results; Sets 2024 Guidance
Rhea-AI Summary
Surgery Partners, Inc. (NASDAQ:SGRY) announced a positive financial performance for the fourth quarter and full year 2023. Revenue increased by 8.0% to $2.74 billion for the full year and 4.0% to $735.4 million for the fourth quarter. Adjusted EBITDA rose by 15.2% to $438.1 million for the full year and 17.8% to $142.3 million for the fourth quarter. Days adjusted same-facility revenues also saw significant growth. Despite a net loss for both periods, the company remains optimistic for 2024 with revenue expected to exceed $3.0 billion and Adjusted EBITDA over $495 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.6%
Tags
earnings
-
News
Surgery Partners, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call Details
Rhea-AI Summary
Surgery Partners, Inc. (NASDAQ:SGRY) will release its fourth quarter 2023 results on February 26, 2024, followed by a conference call at 8:30 a.m. (Eastern Time). Interested parties can join the call via phone or webcast. The company's website will also host a replay of the call for a limited time.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.62%
Tags
earnings
-
News
Surgery Partners, Inc. Reaffirms 2023 Full Year Guidance and Provides 2024 Initial Adjusted EBITDA Outlook
Rhea-AI Summary
Surgery Partners, Inc. (SGRY) reaffirms its 2023 Adjusted EBITDA guidance of $436-440 million and 2023 Revenue guidance of approximately $2.75 billion. The company projects 2024 Adjusted EBITDA to be greater than $495 million. Management will be meeting with investors at the 42nd Annual J.P. Morgan Healthcare Conference, including a presentation at 5:15 p.m. ET. Interested parties can listen to a webcast of the event on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.4%
Tags
none
News
Surgery Partners, Inc. to Present at Upcoming Investor Conference
Rhea-AI Summary
Surgery Partners, Inc. (NASDAQ: SGRY) announced that CEO Eric Evans and CFO Dave Doherty will present at the J.P. Morgan Healthcare Conference on January 8, 2024. The presentation will be available via webcast on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.97%
Tags
conferences
-
News
Surgery Partners, Inc. Announces Proposed Secondary Offering of Common Stock
Rhea-AI Summary
Surgery Partners, Inc. (Nasdaq: SGRY) announced an underwritten secondary offering of 8,000,000 shares of the Company’s common stock by certain stockholders. The offering is subject to market conditions, and the Selling Stockholders will receive all net proceeds. Jefferies LLC is the sole underwriter. The shares are being offered pursuant to an effective shelf registration statement previously filed with the SEC.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.28%
Tags
offering
-
News
Surgery Partners, Inc. Completes Refinancing Transaction
Rhea-AI Summary
Surgery Partners, Inc. (NASDAQ: SGRY) announced a new $1.4 billion senior secured term loan for its subsidiary, Surgery Center Holdings, Inc., with favorable terms, extended maturity date, and reduced interest costs. The company also plans to increase its existing revolving credit facility, expecting to close the new credit facilities in December 2023. The CFO highlighted the support from investors and the banking syndicate, emphasizing the improved liquidity position and potential for continued growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.78%
Tags
none
News
Surgery Partners, Inc. Announces Third Quarter 2023 Results
Rhea-AI Summary
Surgery Partners, Inc. (NASDAQ:SGRY) reported $674.1 million in Q3 2023 revenues, an 8.6% increase. Adjusted EBITDA was $105.5 million, up 9.7%. Net loss was $4.9 million. Full-year Adjusted EBITDA guidance was raised to $436-440 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.99%
Tags
earnings
Stock SGRY logo
Surgery Partners Inc

Nasdaq:SGRY

SGRY Rankings

#1507 Ranked by Market Cap
#3181 Ranked by Stock Gains
N/A Ranked by Dividends

SGRY Stock Data

3.33B
74.36M
1.23%
107.55%
6.54%
General Medical and Surgical Hospitals
Health Care and Social Assistance
Link
United States
Brentwood

About SGRY

surgery partners is a leading operator of surgical facilities and ancillary services with more than 180 locations nationwide. we provide exceptional integrated healthcare experiences between our providers and patients. our diverse company operates multiple types of healthcare services dedicated to improving the quality of care in a convenient and cost-effective manner. the support of our ancillary services is one of many unique attributes that differentiate us from our competitors. these services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, optical services and specialty pharmacy services. our integrated approach to advancing markets allows for flexibility to provide care on an individualized, local market basis. whether entering into a new market with surgical facilities, ancillary services or joint ventures with health systems, or furthering an existing market’s growth potential by focusing on base busines